Howard Marks Sorrento Therapeutics, Inc. Transaction History

Oaktree Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 25, 2023	BUY	$0.17 - $1.19 $22,780 - $159,460	134,000 New	134,000 $48,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $19,840 - $37,280	-16,000 Reduced 10.67%	134,000 $269,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $74,400 - $115,680	16,000 Added 11.94%	150,000 $697,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $1.18 Million - $1.86 Million	-186,000 Reduced 58.13%	134,000 $1.3 Million
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $1.54 Million - $3.62 Million	219,500 Added 218.41%	320,000 $2.65 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $173,865 - $679,380	100,500 New	100,500 $631,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Oaktree Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Oaktree Capital Management LP and Howard Marks with notifications on news.